Sami Labs Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
7
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 21, 2026The maintenance fee for Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof (US 10,293,008) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
- 1 fee due Dec 18, 2026The maintenance fee for Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof (US 10,323,227) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 2 fees due Mar 10 to 24, 2027 · next Mar 10
- 2 fees due May 19, 2027
- 1 fee due Jun 29, 2027The maintenance fee for Composition and method for the protection of articular cartilage (US 9,220,703) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for Skin Care Applications of Extracellular Metabolites from Bacillus Coagulans (US 11,865,203) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 2 fees due Aug 4 to 11, 2027 · next Aug 4
- 1 fee due Sep 17, 2027The maintenance fee for Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof (US 10,588,844) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
- 1 fee due Oct 7, 2027The maintenance fee for Beverage compositions containing Bacillus coagulans MTCC 5856 (US 10,609,935) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
- 1 fee due Nov 3, 2027The maintenance fee for Anti-obesity potential of Calebin A (US 9,328,330) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,253,324 | Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers In force · From the USPTO record | In force | From the USPTO record | |
| US 8,193,156 | Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,071,043 | Oleanoyl Peptide Composition and Skin Hydration In force · Medium confidence | In force | Medium confidence | |
| US 8,987,212 | Oleanoyl Peptide Composition and a Method of Treating Skin Aging In force · Low confidence | In force | Low confidence | |
| US 8,329,095 | Preservative system for cosmetic formulations—compositions and methods thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,003,614 | Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,247,003 | Protective compositions for dermal papilla cells In force · From the USPTO record | In force | From the USPTO record | |
| US 8,329,743 | Compositions and its use in treating obesity or inducing weight loss In force · From the USPTO record | In force | From the USPTO record | |
| US 8,933,121 | Anti-obesity Potential of Calebin A In force · High confidence | In force | High confidence | |
| US 9,737,502 | Calebin A for hepatic steatosis In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 60: 20 lapsed for an unpaid fee · 21 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 no status recorded